SELLAS Life Sciences Group, Inc. (SLS)
3.77
+0.46
(+13.90%)
USD |
NASDAQ |
Dec 31, 16:00
3.85
+0.08
(+2.12%)
After-Hours: 20:00
SELLAS Life Sciences Group Research and Development Expense (TTM): 15.73M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| GT Biopharma, Inc. | 4.026M |
| Geron Corp. | 81.32M |
| ADMA Biologics, Inc. | 3.776M |
| Lyell Immunopharma, Inc. | 140.98M |
| NovaBay Pharmaceuticals, Inc. | -- |